We report the case of a 59-year-old male smoker with hypertension and dyslipidemia who, in 2007, was diagnosed with atrial fibrillation and patent foramen ovale (PFO) after suffering a cerebral ischemic attack in the region of the middle cerebral artery. The high risk of a further cerebral ischemic attack (score of 3 on the CHADS 2) was an indication for long-term oral anticoagulation. However,...

OBJECTIVES The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASD II) using Amplatzer septal occluders (ASO). BACKGROUND Only immediate-, short-, and intermediate-term results of ASO implantation are known so far. METHODS Between September 1995 and January 2000, 151 patients underwent a successful percutaneous closure of ASD ...

https://doi.org/10.4068/cmj.2017.53.2.171 C Chonnam Medical Journal, 2017 Chonnam Med J 2017;53:171-172 Corresponding Author: Yun Ju Lim Division of Pediatric Cardiology, Department of Pediatrics, Jeju National University School of Medicine, 15 Aran 13 gil, Jeju 23241, Korea Tel: +82-64-717-1800, Fax: +82-64-717-1656, E-mail: [email protected] Article History: Received March 17, 2017 Revised A...

Patent foramen ovale (PFO) has been known to be the cause of transient ischemic attacks or stroke, and transcatheter device closure has been the treatment of choice for these defects. Combined defect of abnormal drainage of left superior vena cava (LSVC) to left superior pulmonary vein (LSPV) in PFO patients is an uncommon combination, and both can act as a pathway for paradoxical embolism. We ...

BACKGROUND Transcatheter closure of secundum type atrial septal defect (ASD) has become a standard procedure in most medical centers. Although the procedure is invasive and has a shorter recovery duration and a lower complication rate compared with surgery, it is not risk-free. In this retrospective chart review case series, we report our experience of management of complications after placemen...

BACKGROUND Transcatheter occlusion of the patent ductus arteriosus (PDA) is a minimally invasive treatment. The appropriate device size is chosen based on the angiographic measurement of the PDA. The current study aimed to assess the relationship between the transthoracic echocardiographic (TTE) measurements of the PDA prior to the occlusion procedure and the actual size of the deployed device....

this is a case presentation of a 26-year-old woman with a moderate-sized atrial septal secundum defect (17mm) who underwent catheterism, during which an amplatzer septal occluder number 26 was inserted successfully. on the second postoperative day, she deteriorated and a clinical examination showed a typical tamponade. after a percutaneous aspiration of the pericardial cavity and transient impr...

background: transcatheter occlusion of the patent ductus arteriosus (pda) is a minimally invasive treatment. the appropriate device size is chosen based on the angiographic measurement of the pda . the current study aimed to assess the relationship between the transthoracic echocardiographic (tte) measurements of the pda prior to the occlusion procedure and the actual size of the deployed devic...

An alternative to the surgical repair of secundum type atrial septal defects (ASD) and of patent ductus arteriosus (PDA) is transcatheter closure. However, there is limited information about the efficacy of using percutaneous devices to close multiple ASDs. An 8-year-old female patient was admitted to our hospital with a cardiac murmur. A large secundum multi-fenestrated ASD (17 mm, 4.5 mm, 3 m...